InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Daruwala Paul, Chief Operating Officer. Insider active across 1 companies, notably Cidara Therapeutics, Inc.. In total, 5 reports have been recorded. The latest transaction was disclosed on 31 March 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations5 total
050,000 shares0
Common Stock
SEC:0001610618-22-000019:0·
09,900 shares0
Common Stock
SEC:0001209191-22-002604·
09,900 shares0
Common Stock
SEC:0001209191-22-002604:0·
0132,000 shares0
Common Stock
SEC:0001610618-21-000091·
0132,000 shares0
Common Stock
SEC:0001610618-21-000091:0·
5 of 5 declarations
About Daruwala Paul
Paul Daruwala serves as the Chief Operating Officer of Cidara Therapeutics, Inc. In this role, he is responsible for managing the daily operations of the company. Paul brings expertise in operational management and strategy, enabling him to effectively lead Cidara's initiatives. His experience contributes to the efficiency and performance of the company.
